Inventor · disambiguated record
Daniel Eduardo Gomez
Also filed as: GOMEZ DANIEL E · GOMEZ DANIEL EDUARDO · GÓMEZ DANIEL EDUARDO
7 granted patents·1 pending application·36 citations·filing 2001–2020
79Inventor score
Files withUNIV NAC QUILMES3CT INGENIERIA GENETICA BIOTECH2CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN CONICET1RODRIGUEZ SILVIO ERNESTO PEREA1ROMIKIN S A1
Top patents by PatentIndex Score
8 records- 0179US6693082B2Method of inhibiting metastatic dissemination using desmopressinUNIV NAC QUILMES·Filed 2001·Granted Feb 17, 2004·29 cites·9 claims
- 0273US9278118B2Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugsCT INGENIERIA GENETICA BIOTECH·Filed 2014·Granted Mar 8, 2016·1 cites·6 claims
- 0373US8871725B2Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugsRODRIGUEZ SILVIO ERNESTO PEREA·Filed 2007·Granted Oct 28, 2014·4 cites·11 claims
- 0472US9226946B2Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugsCT INGENIERIA GENETICA BIOTECH·Filed 2014·Granted Jan 5, 2016·1 cites·22 claims
- 0552US7265200B21-desamino-8-D-arginyl vasopressin analogsROMIKIN S A·Filed 2003·Granted Sep 4, 2007·1 cites·14 claims
- 0647US12280059B2Acyl-CoA synthetase 4 (ACSL4) inhibitory compoundCONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN CONICET·Filed 2020·Granted Apr 22, 2025·0 cites·8 claims
- 0744US2009324708A1Compound having inhibitory activity on a rho-gtpase cell protein, a process for obtaining the same, pharmaceutical compositions comprising thereof and a method for the treatment of rho-gtpase cell protein-mediated conditionUNIV NAC QUILMES·Filed 2007·Application pending·0 cites
- 0830US9745257B2Phenyl-guanidine derivativesUNIV NAC QUILMES·Filed 2012·Granted Aug 29, 2017·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →